MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

Home » Boston Scientific completes Asthmatx buyout

Boston Scientific completes Asthmatx buyout

By

Asthmatx, BSX logos

Asthmatx Inc. is now a wholly-owned subsidiary of Boston Scientific Corp. (NYSE:BSX).

Natick, Mass.-based Boston Scientific today announced the completion of the deal, which called for it to pay $193.5 million in cash up front for Asthmatx. The acquisition could cost BoSci an additional $250 million if revenue milestones are met through 2019.

Sunnyvale, Calif.-based Asthmatx makes a catheter-based bronchial thermoplasty procedure for severe asthma, according to a joint press release. The Alair procedure is designed to “reduce excess airway smooth muscle” by delivering thermal energy directly to lung tissue via a bronchoscope, according to Asthmatx. The company won 510(k) clearance from the Food & Drug Administration in April for the Alair treatment, which is cleared for patients at least 18 years who haven’t responded to conventional drug therapies. It’s also cleared for sale in the European Union under a CE Marking.

The companies signed the agreement for the merger in September.

BSX CEO Ray Elliott said the deal, expected to dilute earnings per share by 2 cents in 2011 and 2012, “represents an important step in the execution of our strategy to realign Boston Scientific’s portfolio … by buying or building products we understand, to be sold through sales forces we already have.”

“Given the large under-served patient population and this innovative technology, we expect this transaction to provide meaningful revenue growth in the midterm,” Elliott said in prepared remarks.”

In a note to investors, Leerink Swann analyst Rick Wise said that although the acquistion might not move BSX shares higher, it “looks to us like directionally very positive news.”

“The deal — the first in some time — importantly highlights CEO Ray Elliot’s determination (and ability) to move past the current portfolio’s growth/profitability challenges and forge into new areas of MedTech — seeking big new markets that can potentially add growth to the BSX product portfolio,” Wise wrote. “We expect there will be other deals of this type in coming months and years as Elliot reshapes the portfolio. As the gradual process of rebuilding BSX unfolds, we expect the stock to move higher over time.”

Filed Under: Uncategorized

In case you missed it

RSS From Medical Design & Outsourcing

  • BD, Mitsubishi Gas Chemical partner on better materials for plastic syringes
    BD (NYSE:BDX) announced that it partnered with Mitsubishi Gas Chemical Company on applying new technology to pre-fillable syringes. MGC develops the Oxycapt technology designed to integrate the best of plastic and glass for plastic syringes. BD and Tokyo-based MGC will work together to apply Oxycapt technology to the next generation of pre-fillable syringes (PFS) for advanced… […]
  • Ambu replaces CEO with new leadership
    Ambu today said it has hired board member Britt Meelby Jensen to replace CEO Juan Jose Gonzalez, effective tomorrow. “Since Juan Jose Gonzalez joined as CEO in 2019, Ambu has made good progress and achieved important milestones on the strategic transformation into the world’s largest single-use endoscopy company,” Ambu Chair Jørgen Jensen said in a… […]
  • AdvaMed joins Biden’s Joint Supply Chain Resilience Working Group
    AdvaMed executive Abby Pratt has joined the executive committee for the Biden administration’s Joint Supply Chain Resilience Working Group, the medtech industry association said today. The working group’s members from government and industry will assist with implementation of the National Strategy for a Resilient Public Health Supply Chain. Pratt oversees supply chain issues as SVP… […]
  • Toray develops new stretchable film for medical devices
    Toray Industries has a new stretchable film based on its proprietary polymer Reactis technology, with potential applications that include robotics and biological and industrial sensors. Tokyo-based Toray said it shipped samples to customers and plans research and development efforts to commercialize the new grade of film. “Recent years have increased the potential for developing stretchable… […]
  • Google Health hires FDA’s chief digital health officer
    Former FDA Chief Digital Health Officer of Global Strategy and Innovation Bakul Patel has started a new job with Google after 13 years with the regulatory agency. Patel became senior director, global digital health strategy and regulatory for Google Health earlier this month, he said on LinkedIn. Patel recounted highlights of his “incredible journey since… […]
  • Expect more heart and lung failure years after COVID, Abbott’s heart failure CMO says
    Two years into the COVID-19 pandemic, we know more than ever about the SARS-CoV-2 virus and how quickly it moves to ravage the human body. What remains to be seen is how the virus — and perhaps more importantly, our immune system’s response to it — will affect the health of people long after infection,… […]
  • FDA moves forward with Voluntary Improvement Program to bolster medical device quality
    Kathryn Burke, Emergo Group The U.S. Food and Drug Administration has issued new draft guidance to establish a full-blown voluntary program for improving quality-related processes in medical device manufacturing following promising results of a pilot program. The FDA guidance stems from a pilot undertaken by the agency along with the Medical Device Innovation Consortium (MDIC) in 2018.… […]
  • How Minnetronix Medical helped Lazurite with its wireless surgical camera
    Minnetronix Medical (St. Paul, Minnesota) has played an important development and manufacturing partner role with Lazurite’s wireless surgical camera system. It’s been nearly two months since Lazurite (formerly Indago) announced FDA 510(k) clearance of its ArthroFree system. ArthroFree combines proprietary low-heat, high-intensity Meridiem light engine technology with advanced camera, battery and wireless transmission technologies and… […]
  • Instron releases TrendTracker data analysis workflow platform
    Instron announced that it released the TrendTracker module in Bluehill Central for accelerating data analysis workflows. Norwood, Massachusetts-based Instron designed TrendTracker with an intuitive interface to improve the data analysis workflow of single or multi-location materials testing laboratories. According to a news release, the platform features quick searching and the ability to display and analyze… […]
  • Henry Schein hires former Medline veteran to drive ‘One Distribution’ push
    Henry Schein (Nasdaq:HSIC) today named Dirk Benson as VP and chief commercial officer of the medical device manufacturer and distributor’s North America Distribution Group (NADG). Melville, New York-based Henry Schein is the world’s largest provider of health care supplies and services for office-based dental and medical practitioners, and NADG is the company’s largest business group. The… […]
  • The road to a robot: Medtronic’s development process for its Hugo RAS system
    Elephants are the perfect analogy for surgical robotics, Medtronic (NYSE:MDT) VP of Marketing for Surgical Robotics Mike Stow says. Speaking on the “Road to a robot: Designing technology to address unmet needs & barriers” panel at DeviceTalks Boston last week, Stow explained that elephants are big, taking up a lot of space and that they eat a lot, making… […]

Leave a Reply